Napredna pretraga

Pregled bibliografske jedinice broj: 345346

Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study


Petrač, Dubravko; Radić, Berislav; Radeljić, Vjekoslav; Hamel, Duško; Filipović, Jakša
Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study // Croatian Medical Journal, 46 (2005), 6; 922-928 (međunarodna recenzija, članak, znanstveni)


Naslov
Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study

Autori
Petrač, Dubravko ; Radić, Berislav ; Radeljić, Vjekoslav ; Hamel, Duško ; Filipović, Jakša

Izvornik
Croatian Medical Journal (0353-9504) 46 (2005), 6; 922-928

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
pacing; persistent atrial fibrillation; AV node ablation

Sažetak
Aim. To compare ventricular rate responsive (VVIR) pacing with dual chamber rate responsive (DDDR) pacing and antiarrhythmic drugs for the treatment of patients with persistent atrial fibrillation after atrioventricular node ablation. Methods.One hundered two patients with persistent atrial fibrillation eligible for the atrioventricular node ablation were randomly assigned to the therapy with either VVIR pacemaker (n=52) or DDDR pacemaker and antiarrhythmic drugs (n=50). After ablation, patients in both pacing groups were assigned to take anticoagulant therapy. The primary end point was stroke or death from cardiovascular causes. Results. After a mean follow-up of 26.6+-9.5 months, there was no difference in the stroke or death rates between patients with VVIR pacing (6 or 5.2% per year) and those with DDDR pacing and antiarrhythmic drugs (6 or 5.9% per year, P=0.930). The observed rates of death from all causes, hospitalization for heart failure, and myocardial ischemia were similar in the two patient groups. There was a significant lower rate of development of permanent atrial fibrillation in patients with DDDR pacing and antiarrhythmic drugs, with a reduction in absolute risk by 56% and relative risk by 64% (32% vs 88%, P<0.001). Conclusion. With respect to cardiovascular death and morbidity, VVIR pacing is not inferior to DDDR pacing and antiarrhythmic drugs for the treatment of patients with persistent atrial fibrillation after atrioventricular node ablation and may be considered as an appropriate therapy for such patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
134-0362979-0119 - Pretkazatelji fibrilacije atrija kod bolesnika s AV blokom i elektrostimulatorom (Diana Delić-Brkljačić, )

Ustanove
KBC "Sestre Milosrdnice"

Citiraj ovu publikaciju

Petrač, Dubravko; Radić, Berislav; Radeljić, Vjekoslav; Hamel, Duško; Filipović, Jakša
Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study // Croatian Medical Journal, 46 (2005), 6; 922-928 (međunarodna recenzija, članak, znanstveni)
Petrač, D., Radić, B., Radeljić, V., Hamel, D. & Filipović, J. (2005) Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study. Croatian Medical Journal, 46 (6), 922-928.
@article{article, year = {2005}, pages = {922-928}, keywords = {pacing, persistent atrial fibrillation, AV node ablation}, journal = {Croatian Medical Journal}, volume = {46}, number = {6}, issn = {0353-9504}, title = {Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study}, keyword = {pacing, persistent atrial fibrillation, AV node ablation} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE